NCT07241663 Surgery for Locally Unresectable Pancreatic Cancer
| NCT ID | NCT07241663 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Azienda Ospedaliera di Padova |
| Condition | Locally Advanced Pancreatic Adenocarcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2025-01-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pancreatic cancer is a severe disease often diagnosed at an advanced stage, when surgery is not possible. New chemotherapy treatments can sometimes shrink the tumor and make surgery an option. This study aims to understand if surgery after such treatments can improve survival and quality of life in selected patients treated at expert centers.
Eligibility Criteria
Inclusion Criteria: * Patients older than 18 years * Patients able to give informed consent * Histologically confirmed pancreatic adenocarcinoma * LAPC stage according to NCCN10 at diagnosis (Figure 1) * Received at least 4 months of induction chemotherapy * RECIST 1.1 stable disease (SD) or partial response (PR) after induction therapy * Patient considered eligible for radical resection by local MDT Exclusion Criteria: * Informed consent withdrawal * Presence of tumor characteristics precluding surgery * Presence of patient significant comorbidities precluding surgery * Unavailable pre-induction therapy abdominal imaging * Pathological confirmation of any tumor different from PDAC
Frequently Asked Questions
Who can join the NCT07241663 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Locally Advanced Pancreatic Adenocarcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07241663 currently recruiting?
Yes, NCT07241663 is actively recruiting participants. Visit ClinicalTrials.gov or contact Azienda Ospedaliera di Padova to inquire about joining.
Where is the NCT07241663 trial being conducted?
This trial is being conducted at Padova, Italy.
Who is sponsoring the NCT07241663 clinical trial?
NCT07241663 is sponsored by Azienda Ospedaliera di Padova. The trial plans to enroll 150 participants.